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Introduction
Hyperspectral imaging – or spectral imaging – was first used in the
material, food and biological domains. But it is increasingly being
employed by pharmaceutical professionals, since it combines the dual
advantages of spectroscopic techniques and imaging. Hyperspectral
imaging allows the user to acquire the spectrum at each pixel of a
defined image. It is thus possible to visualise properties invisible to the
naked eye, as the spatial distribution of the constituents of a
pharmaceutical solid form, the polymorphic form and so on. The
available information is thus a function of the spectroscopic technique
used. Each technique has its advantages, disadvantages and specificities
and must be selected according to the information sought 1-2. 
Raman hyperspectral imaging is an increasingly used tool in the pharmaceutical field because it allows for the
investigation of many characteristics on a solid sample. This paper delves into Raman spectroscopy and imaging,
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After a hyperspectral imaging analysis, the data obtained are presented
as a three-dimensional matrix, the so-called hyperspectral data cube.
This matrix contains two spatial dimensions (x and y) and a spectral
dimension (λ). The treatment of this cube is divided into three parts:
pre-processing, processing and image processing. Firstly, the three-
dimensional data cube must be unfolded in a two-dimensional matrix
concatenating the spatial dimensions. The pre-processing step reduces
the artifacts and makes it possible to work under better conditions.
Different treatments are possible: spikes and dead pixel correction, 
de-noising treatment, baseline correction and normalisation3-5. 
A corrected data cube is thus obtained. 
After pre-processing, the data are processed using either univariate
data analysis if a specific peak is not interfered with by any adjacent
peak or multivariate data analysis (MVA). The latter consists of resolu -
tion, regression or classification techniques that can be applied
depending on the sought information. The resolution techniques divide
the pre-processed data in a matrix of concentration and a matrix of
spectra. Some techniques do not need prior knowledge and are called
explora- tory techniques among which Principal Component Analysis
(PCA) is the most often used. PCA indicates the variables which most
impact the variability of the data, reducing the number of dimensions
of the problem. Therefore, it may be used to estimate the number of
compounds present in the studied sample. 
Finally, in order to obtain more chem ically meaningful and reliable
information, Multivariate Curve Resolution – Alternating Least Squares
(MCR-ALS) may be applied. This technique is able to approxi mate the
qualitative and quantitative composition of an unknown sample
without a priori information. If quantitative information is desired, one
may use the Classical Least Squares (CLS) algorithm. This performs
‘least squares regression’ using the pure spectra of the compounds. 
It is thus very sensitive to any variation which impacts spectra. If more
complex or noisier data are used, it is wise to use a Partial Least Squares
(PLS) algorithm. It establishes a linear model with a calibration set.
Therefore, it requires analysing calibration samples with a reference
technique (e.g. HPLC). This time-consuming approach provides more
robust and precise results for well-established formulations. If the
objective is to extract qualitative information and to classify data in
groups (e.g. to determine the presence of counterfeits) classification
techniques such as the K-means algorithm are used2,4-7. 
Raman hyperspectral imaging: applications
Raman hyperspectral imaging is an interesting tool that can be used to
analyse a pharmaceutical sample. Some of its uses and advantages are
presented in the following paragraphs.
1. Identification of the composition of a sample
An important thing to consider when analysing pharmaceutical drugs is
the determination of the composition of a sample even if the
components are unknown. Indeed, it is important to evaluate whether
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Raman hyperspectral imaging provides an accurate 
tool for the qualitative and quantitative analysis of 
a pharmaceutical solid form
the qualitative composition of a sample 
is correct, to track the apparition of the
impurities during a stability study or even to
study the interactions of the compounds. 
Distribution maps illustrating the
compo sition of tablets are presented in
Figures 1a and b. After acquiring the data
cube, pre-processing and processing algo -
rithms were applied in order to extract
spectra of the different components to
identify the composition. It then becomes
possible to observe the spatial distribution
of the identified compounds within the
sample as it is shown in Figures 1a and b.
Moreover, sometimes it is interesting to
identify different polymorphic forms of a
compound. It is possible to determine them and evaluate their spatial
distributions by acquiring the Raman spectra of each solid-state. 
2. Size determination
It can be interesting to investigate the size of various parts of a sample
or the thickness of the coating of a tablet. Raman chemical imaging of
a coated pellet is presented in Figure 2. The thickness of the coating
was measured and in this case was equal to 50µm. Determining and
monitor ing this parameter during a production process is important.
Indeed, the coating of a pharma ceutical solid form has a role to play on
the API release and on the API activity.
Moreover, using a confocal Raman microspectrometer, it is possible
to acquire a three-dimensional image of a pellet, and to acquire spectra
on the z dimension and so analyse different characteristics inside a
sample according to the confocality parameter. The determination of
the composition and the spatial distribution of the pellet are presented
in Figure 3a and the volume/three-dimensional image of the pellet is
presented in Figure 3b. 
3. Homogeneity
Because of the combination of spectral and spatial information, 
Raman chemical imaging is able to determine the spatial distribution 
of a specific compound in a sample. Indeed, two samples may 
have the same API content, the same results for dissolution tests 
and so on, but have a different spatial homogeneity. As shown in
Figures 1a and b, it is possible to note the differences at a spatial 
level of two different samples which have the same pharmaco-
technical properties and API content. 
The obtained chemical images highlight
differences in formulation architecture 
and manufacturing. 
4. Quantitative approach
In addition to qualitative information
(identification, solid-state and so on) it is
possible to obtain quantitative information
with Raman hyperspectral imaging. Calibra -
tion samples are prepared and the model is
developed based on the Raman spectra. This
model is compared with a reference
technique (e.g. HPLC). The advantages of
developing a quantitative model with Raman
hyperspectral imaging is that it is developed
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Figures 1a and b: Distribution maps indicating the composition and the spatial distribution of two pharmaceutical
tablets with the same pharmaco-technical properties and API content
(a) (b)
Figure 2: Distribution map revealing the coating thickness of a pharmaceutical pellet
Figure 3: Distribution maps indicating (a) the composition and the spatial distribution of a pharmaceutical pellet and
(b) a three-dimensional image of a pharmaceutical pellet
(a) (b)
at a pixel level (Figure 4) and not at a sample level without the
destruction of the sample.
5. Other applications
It is also possible to identify counterfeit drugs. The main advantage of
Raman hyperspectral imaging in this case is to detect the presence 
of excipients that are absent from the original formulation. The
application of classification techniques on drugs allows one to separate
the counterfeit drugs from the original ones.
Raman hyperspectral imaging can also be used to gain an
understanding of processes; for example, it is able to detect process
variability, dysfunctions and so on, controlling the final product quality.
Indeed, using Raman hyperspectral imaging for this purpose ensures
product quality during the entire manufacturing process. It is thus a
versatile and nondestructive tool for qualitative and quantitative
analysis of solid pharmaceutical formulations2,4,7-8. 
Conclusion
Raman hyperspectral imaging provides an accurate tool for the
qualitative and quantitative analysis of a pharmaceutical solid form.
Indeed, it combines the advantages of Raman spectroscopy and
imaging, bringing together spectral and spatial information. The
technique is able to identify the composition of a sample, to 
determine the solid-state of the different compounds and to calculate
the size of some parts in the sample. It is also possible to identify
counterfeits or to increase understanding of a manufacturing process.
One of the most important characteristics of Raman chemical imaging
is the ability to investigate spatial distribution. Indeed, it determines
the homogeneity of the sample at a spatial level indicat- ing the
repartition of the components on the sample. Hyperspectral Raman
imaging is thus an accurate and complete tool to analyse
pharmaceutical samples.
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Figure 4: Distribution maps at different API concentrations
Because of the combination of spectral 
and spatial information, Raman chemical imaging 
is able to determine the spatial distribution 
of a specific compound in a sample
